The ICER of DKK 19,167 per QALY gained was far below the estimated willingness-to-pay threshold in Denmark (DKK 458,134969,518 per QALY gained) and semaglutide remained a highly cost-effective treatment compared with placebo
Every visit is built on trust, education, and collaborationbecause aesthetic care should feel empowering, not intimidating
Slower Weight Loss: Provider Evaluation Framework Patients with type 2 diabetes, high baseline BMI, or insulin resistance often experience more dramatic monthly loss initially
Currently, commercial products containing IGF-1 exist for transdermal application using a dermaroller, usually in combination with other growth factors such as bFGF (basic fibroblast growth factor) and VEGF (vascular endothelial growth factor), copper peptide, hyaluronic acid, coenzyme Q, vitamins B3, B6, and B5, and amino acids (arginine and lysine)
PlexusDx supports precision-wellness approaches by helping you and your provider evaluate which GLP-1 strategy aligns with your clinical needs and genetic predispositions
